ResultsIQ

ResultsIQ › Latest results › Sharda Cropchem Limited

Sharda Cropchem Limited call transcript summary

NSE: SHARDACROP · BSE: 538666

Call transcript of 31 Oct 2025, summarised by AI from the filing.

Sharda Cropchem filed the audio recording of its Q2 FY 2025-26 earnings call held on 31 October 2025.

Key takeaways

  1. Earnings call Sharda Cropchem held a conference call with analysts and investors on 31 October 2025 at 12.30 P.M. IST to discuss Q2 FY 2025-26 financial results.
  2. Audio link The audio recording is available on the company's website.
  3. Disclosure The filing was made under Regulation 30 of the SEBI Listing Regulations, 2015.
  4. Company Secretary Jetkin Gudhka, Company Secretary & Compliance Officer, signed the filing.

Original filing on BSE

Sharda Cropchem Limited Q1 FY27 results

As filed: Revenue ₹1,074 cr (+9% year on year), EBITDA ₹186 cr (−14% year on year), PAT ₹88.0 cr (−38% year on year), EBITDA margin 17.3% (−461 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹2,065 cr (+13% year on year), EBITDA ₹487 cr (+61% year on year), PAT ₹319 cr (+56% year on year), EBITDA margin 23.6% (+702 bps). Score 64 of 100, In line with trend. Revenue, EBITDA and profit growth were below the company's own trend. EBITDA margin rose 702 bps year on year. Profit rose ₹115 cr on a year ago, more than the ₹61.0 cr it added the year before. Share price after the results: −19.7% in 30 days (Nifty 500: +1.3%).
  • Q3 FY26: Revenue ₹1,289 cr (+39% year on year), EBITDA ₹241 cr (+111% year on year), PAT ₹145 cr (+300% year on year), EBITDA margin 18.7% (+643 bps). Score 88 of 100, Above trend. Revenue growth was above the company's own trend; EBITDA growth was in line with it; profit growth was well above it. EBITDA margin rose 643 bps year on year. Revenue grew on the previous quarter, against its usual seasonal pattern. Profit rose ₹114 cr on a year ago, more than the ₹26.0 cr it added the year before. Share price after the results: +43.5% in 29 days (Nifty 500: +0.4%).
  • Q2 FY26: Revenue ₹929 cr (+20% year on year), EBITDA ₹133 cr (+48% year on year), PAT ₹74.0 cr (+76% year on year), EBITDA margin 14.3% (+273 bps). Score 37 of 100, Below trend. Revenue, EBITDA and profit growth were in line with the company's own trend. EBITDA margin rose 273 bps year on year. Other income 34% of PBT. Tax rate 14%. Revenue fell 6% from last quarter. Share price after the results: −9.6% in 29 days (Nifty 500: −0.1%).
  • Q1 FY26: Revenue ₹985 cr (+25% year on year), EBITDA ₹216 cr (+177% year on year), PAT ₹143 cr (+300% year on year), EBITDA margin 21.9% (+1,000 bps). Score 73 of 100, Above trend. Revenue growth was in line with the company's own trend; EBITDA growth was above it; profit growth was well above it. EBITDA margin rose 1000 bps year on year. Revenue fell 46% from last quarter. Revenue rose ₹200 cr on a year ago, more than the ₹147 cr it added the year before. Share price after the results: +5.8% in 28 days (Nifty 500: −1.3%).
  • Q4 FY25: Revenue ₹1,829 cr (+39% year on year), EBITDA ₹303 cr (+19% year on year), PAT ₹204 cr (+43% year on year), EBITDA margin 16.6% (−279 bps). Score 59 of 100, In line with trend. Revenue growth was above the company's own trend; EBITDA growth was below it. EBITDA margin fell 279 bps year on year. Consolidated profit +43% but standalone +0%. Revenue grew on the previous quarter, against its usual seasonal pattern. Share price after the results: +43.2% in 30 days (Nifty 500: +2.5%).
  • Q3 FY25: Revenue ₹929 cr (+47% year on year), EBITDA ₹114 cr (+63% year on year), PAT ₹31.0 cr (+300% year on year), EBITDA margin 12.3% (+120 bps). Score 71 of 100, Above trend. Revenue growth was well above the company's own trend. EBITDA margin rose 120 bps year on year. Profit fell 26% from last quarter.
  • Q2 FY25: Revenue ₹777 cr (+34% year on year), EBITDA ₹90.0 cr (+300% year on year), PAT ₹42.0 cr, EBITDA margin 11.6% (+797 bps). Score 82 of 100, Above trend. EBITDA margin rose 797 bps year on year. Other income 54% of PBT. Tax rate 9%. Not enough history for a trend yet: scored on growth alone.

Past price moves after results do not indicate future moves. Not a recommendation.

Sharda Cropchem Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.